A Drug Interaction Study of JNJ-31001074 and Ketoconazole in Healthy Volunteers

Summary

This is an open-label (both the physician and healthy volunteer know which treatment will be administered) study to assess the pharmacokinetics (process by which JNJ-31001074 is absorbed, distributed, metabolized, and eliminated by the body) of JNJ-31001074 when taken alone and in combination with ketoconazole. The study consists of three phases: a screening phase to determine eligibility, an open-label treatment phase consisting of three periods and an end-of study/early withdrawal assessment phase.

Timeline

Start

2009-11

Primary completion

—

Completion

2009-12

Drugs

Indications

No indication recorded.